Celent projects healthy growth in IT spending in the sell-side OMS market in the U.S., representing a market opportunity potentially worth US$250 million over the next three years.

After years of benign neglect by the industry, the OMS market has suddenly taken center stage as the U.S. securities industry continues to struggle with cost reduction and straight-through processing. In a new report entitled, "Sell-side OMS Market in the US: Changing of the Guards," Celent takes a close look at some key trends shaping the future of the U.S. OMS market and provides projections for potential market opportunities for the next three years.

"We are seeing a rebirth of the OMS market in the U.S. as firms continue to look for ways to increase automation and operational efficiency," says Celent analyst Sang Lee, the author of the report. Lee adds, "This is very much a buyer's market, as new entrants are looking for opportunities. We expect a major shake-up in the status quo of the OMS technology market in the next few years."

A companion report evaluating the leading OMS vendors will soon follow the publication of this report.